Hospice Fraud Alert: CMS Maintains Nationwide Enrollment Restrictions in 2026

August 10, 2026 | JacobiJournal.com — Federal healthcare regulators continue tightening oversight of hospice and home health providers as the Centers for Medicare & Medicaid Services (CMS) maintains a temporary nationwide enrollment moratorium designed to address concerns about fraud, waste, and abuse within Medicare. The action places particular attention on hospice fraud, an area federal officials have identified as carrying significant program-integrity risks.

CMS implemented the six-month nationwide moratorium on May 13, 2026, halting new Medicare enrollment for hospice and home health agencies. The restriction applies to initial enrollment applications and certain changes in majority ownership. CMS states that the moratorium can be extended in additional six-month periods if the agency determines that continued restrictions are necessary.

The August 2026 status of the moratorium is therefore not a newly announced restriction. Instead, it represents the continuation of a federal enforcement strategy that began in May and remains active during the current six-month period. CMS’s provider enrollment page was updated July 20, confirming that the hospice and home health moratorium remained in effect.

The policy has particular relevance for California, where CMS has identified the state among jurisdictions with elevated fraud risk involving newly enrolled hospice providers. Federal officials say the restrictions are intended to prevent potentially problematic operators from entering the Medicare program while investigators increase scrutiny of providers already participating in the system.

CMS Targets High-Risk Hospice and Home Health Enrollment

The federal government is using enrollment controls as a preventive tool against hospice fraud rather than relying exclusively on prosecutions after fraudulent claims have already been submitted. CMS describes the moratorium as part of a broader strategy intended to stop improper billing before new providers gain access to Medicare reimbursement systems.

Under the current restrictions, applications submitted after May 13 by affected hospice and home health providers generally will not be approved. The moratorium also covers certain non-exempt changes in majority ownership, a provision intended to address situations in which ownership changes could potentially be used to obscure control of a healthcare business.

Existing providers are not automatically barred from operating. CMS specifically states that the moratorium does not affect current enrollments, meaning existing hospice and home health providers can continue delivering services to Medicare beneficiaries.

This distinction is important because the federal action is aimed primarily at controlling new entry into high-risk provider categories rather than shutting down legitimate hospice or home health operations across the country.

California Remains a Focus of Federal Fraud Prevention

California is among the states CMS identified for heightened oversight of newly enrolled Medicare hospice providers because of elevated fraud risk. The agency’s May announcement specifically listed California alongside Arizona, Georgia, Ohio, Nevada, and Texas as states receiving increased scrutiny.

The federal focus is significant because California operates a massive healthcare marketplace with substantial Medicare and Medi-Cal participation. Hospice providers serve vulnerable beneficiaries who may require end-of-life care, making accurate eligibility determinations, appropriate treatment, and legitimate billing particularly important.

CMS has stated that it is conducting nationwide hospice site visits, reviewing provider operations, and using data analytics to identify suspicious utilization and compliance patterns. The agency has also introduced a publicly available hospice scoring system intended to increase transparency and help identify providers presenting concerning utilization, quality, or compliance patterns.

These measures demonstrate that federal hospice fraud enforcement is increasingly relying on preventive screening, data analysis, and provider oversight rather than depending solely on criminal investigations after losses occur.

CMS Suspended Payments to Hundreds of Providers

The enrollment moratorium follows other aggressive actions by CMS involving existing hospice and home health providers. According to the agency’s May 13 announcement, CMS suspended payments to approximately 800 hospices and home health agencies suspected of fraud in Los Angeles alone.

Those providers were responsible for approximately $1.4 billion in Medicare spending during the previous year, while CMS reported that roughly $70 million in funds had been suspended at the time of the announcement.

The Los Angeles action highlights why California remains significant in the federal hospice fraud enforcement strategy. CMS is combining payment intervention with enrollment restrictions, site visits, provider screening, and data analysis to address suspected fraudulent activity at multiple stages of the Medicare payment process.

Payment suspension, however, does not itself establish that a provider committed criminal fraud. Federal agencies may suspend payments while investigations proceed when available information indicates that continued reimbursement could expose Medicare to additional improper payments.

Enrollment Controls Address Potentially Vulnerable Entry Points

CMS’s decision to restrict new hospice and home health enrollment reflects the agency’s broader view that preventing questionable providers from entering Medicare can be more effective than attempting to recover fraudulent payments after they have been made.

The agency has described the moratorium as a way to temporarily halt the influx of new providers into healthcare categories considered high risk for fraudulent activity. During the six-month period, CMS intends to increase targeted investigations, use advanced data analytics, and accelerate action against providers suspected of fraud.

The approach also addresses the possibility that bad actors could move between states or healthcare entities to avoid detection. CMS specifically said the nationwide scope is intended to prevent operators from simply shifting across state lines.

For the hospice industry, the policy creates additional scrutiny around ownership structures, enrollment applications, operating locations, billing patterns, and compliance practices.

Existing Providers Remain Subject to Increased Scrutiny

The enrollment restrictions do not eliminate federal oversight of hospice and home health agencies that are already participating in Medicare. Instead, CMS is continuing to use payment reviews, site visits, data analytics, and other program-integrity tools to identify potential hospice fraud involving existing providers.

This distinction is important for legitimate healthcare organizations. The moratorium does not mean that every hospice provider is suspected of wrongdoing. Rather, CMS is using enrollment restrictions as a targeted measure while it evaluates high-risk areas and investigates providers whose billing or operational patterns may warrant additional review.

For providers operating in California and other affected states, the continuing federal scrutiny makes compliance documentation increasingly important. Accurate patient records, appropriate eligibility documentation, legitimate billing, proper ownership disclosures, and adherence to Medicare requirements can help demonstrate that services are being delivered appropriately.

Hospice Eligibility Remains a Critical Enforcement Issue

One area receiving continued attention is hospice eligibility. Medicare hospice benefits are intended for beneficiaries who meet specific eligibility requirements and elect hospice care under applicable federal rules. When providers allegedly enroll patients who do not meet those requirements, the resulting claims can become the subject of hospice fraud investigations.

Federal enforcement agencies have previously pursued cases involving allegations that hospice operators improperly certified patients, encouraged inappropriate hospice enrollment, or billed Medicare for services that did not satisfy program requirements.

The distinction between legitimate clinical judgment and intentional fraud remains important. A disagreement regarding a patient’s prognosis or treatment does not automatically constitute criminal conduct. Fraud investigations generally require evidence supporting allegations of intentional deception or other violations of applicable law.

CMS’s continued use of data analysis and provider reviews allows federal officials to identify unusual patterns that may warrant closer examination without automatically treating every irregularity as fraud.

Data Analytics Play a Larger Role

CMS is increasingly using data to identify potential hospice fraud and other forms of Medicare abuse. Claims data can reveal unusual billing volumes, geographic patterns, patient utilization, ownership relationships, and other characteristics that may justify further investigation.

The agency’s broader strategy involves combining automated analysis with provider site visits and investigative reviews. This approach can help regulators identify patterns across multiple providers rather than evaluating each claim independently.

For example, unusual concentrations of hospice services, rapid growth in patient enrollment, or billing patterns that differ significantly from comparable providers may trigger additional scrutiny. These indicators do not establish fraud by themselves, but they can help investigators determine where additional resources should be directed.

The Moratorium Is Not a Permanent Ban

The current enrollment restriction is temporary. CMS established the moratorium for an initial six-month period and has authority to extend it for additional six-month periods when continued restrictions are considered necessary.

That structure allows CMS to evaluate whether the enrollment controls are reducing risk and whether additional enforcement measures are necessary. It also gives federal officials an opportunity to assess information gathered through investigations, site visits, payment reviews, and data analysis.

For companies considering entering the hospice or home health market, the restrictions create an additional regulatory consideration. Organizations should review CMS enrollment requirements and the applicable moratorium provisions before making business or ownership decisions.

California Providers Face Continued Federal Attention

California’s inclusion among the states identified for heightened hospice oversight means providers in the state should expect continued federal attention to Medicare billing and enrollment practices.

The federal government’s actions also demonstrate that hospice fraud prevention is no longer limited to traditional post-payment investigations. CMS is increasingly combining enrollment controls, payment interventions, provider screening, and predictive data analysis to identify potential problems earlier.

For legitimate providers, stronger oversight can help protect the Medicare program from operators accused of exploiting vulnerable beneficiaries or submitting improper claims. For regulators, the challenge remains ensuring aggressive fraud prevention does not unnecessarily disrupt access to legitimate hospice and home health services.

As the current moratorium period continues, federal officials will likely evaluate the effectiveness of the restrictions and determine whether additional measures are warranted.

Learn more here.

FAQs: Hospice Fraud and CMS Enrollment Restrictions

Why did CMS restrict new hospice enrollment?

CMS imposed the temporary restrictions as part of a broader Medicare program-integrity strategy targeting areas considered vulnerable to fraud, waste, and abuse, including potential hospice fraud.

Does the moratorium close existing hospice providers?

No. The enrollment moratorium primarily restricts new Medicare enrollment and certain ownership changes. Existing providers are not automatically barred from continuing to operate.

Is California included in the federal hospice enforcement effort?

Yes. CMS identified California as one of the states subject to heightened scrutiny involving new hospice providers because of elevated fraud risk.

Does a CMS investigation prove hospice fraud?

No. A payment review, site visit, enrollment restriction, or investigation does not by itself establish criminal wrongdoing. Allegations must be evaluated based on the evidence and applicable legal process.

The continuing federal focus on hospice fraud demonstrates how CMS is expanding preventive oversight of Medicare providers while investigating suspected billing and enrollment abuses. JacobiJournal.com will continue tracking federal healthcare fraud enforcement, Medicare program-integrity actions, California investigations, and regulatory developments affecting healthcare providers and beneficiaries.